The rising prevalence in GLP-1 agonists for diabetes has led to a debate about application forms : transdermal systems versus tablets . Traditionally , GLP-1 treatments were only available in oral form, https://majablay818724.ssnblog.com/39626323/glp-1-transdermal-delivery-systems-vs-oral-medications-what-suitable-for-you